Fulton Bank, N.A. Eli Lilly & CO Transaction History

Fulton Bank, N.A.

$1.19 Billion
Q3 2024

A detailed history of Fulton Bank, N.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Fulton Bank, N.A. holds 13,476 shares of LLY stock, worth $10.7 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

13,476

Previous 13,382 0.7%

Holding current value

$10.7 Million

Previous $12.1 Million 1.46%

% of portfolio

1.01%

Previous 1.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$772.14 - $960.02 $72,581 - $90,241	94 Added 0.7%	13,476 $11.9 Million
Q2 2024 Jul 09, 2024	BUY	$724.87 - $909.04 $1.26 Million - $1.58 Million	1,740 Added 14.95%	13,382 $12.1 Million
Q1 2024 Apr 10, 2024	BUY	$592.2 - $792.28 $191,280 - $255,906	323 Added 2.85%	11,642 $9.06 Million
Q4 2023 Jan 04, 2024	SELL	$525.19 - $619.13 $249,465 - $294,086	-475 Reduced 4.03%	11,319 $6.6 Million
Q3 2023 Oct 04, 2023	BUY	$434.7 - $599.3 $349,498 - $481,837	804 Added 7.32%	11,794 $6.33 Million
Q2 2023 Jul 06, 2023	SELL	$350.74 - $468.98 $151,519 - $202,599	-432 Reduced 3.78%	10,990 $5.15 Million
Q1 2023 Apr 06, 2023	BUY	$310.63 - $364.82 $68,027 - $79,895	219 Added 1.95%	11,422 $3.92 Million
Q4 2022 Jan 05, 2023	SELL	$321.55 - $374.67 $45,338 - $52,828	-141 Reduced 1.24%	11,203 $4.1 Million
Q3 2022 Oct 04, 2022	SELL	$296.48 - $337.87 $78,270 - $89,197	-264 Reduced 2.27%	11,344 $3.67 Million
Q2 2022 Jul 07, 2022	SELL	$278.73 - $327.27 $127,937 - $150,216	-459 Reduced 3.8%	11,608 $3.76 Million
Q1 2022 Apr 05, 2022	BUY	$234.69 - $291.66 $379,259 - $471,322	1,616 Added 15.46%	12,067 $3.46 Million
Q4 2021 Jan 05, 2022	BUY	$224.85 - $279.04 $109,277 - $135,613	486 Added 4.88%	10,451 $2.89 Million
Q3 2021 Oct 05, 2021	BUY	$221.6 - $272.71 $557,988 - $686,683	2,518 Added 33.81%	9,965 $2.3 Million
Q2 2021 Jul 06, 2021	SELL	$180.55 - $233.54 $74,386 - $96,218	-412 Reduced 5.24%	7,447 $1.71 Million
Q1 2021 Apr 05, 2021	SELL	$164.32 - $212.72 $2.49 Million - $3.22 Million	-15,152 Reduced 65.85%	7,859 $1.47 Million
Q4 2020 Jan 07, 2021	BUY	$130.46 - $172.63 $33,528 - $44,365	257 Added 1.13%	23,011 $3.89 Million
Q3 2020 Oct 06, 2020	BUY	$146.22 - $169.13 $167,860 - $194,161	1,148 Added 5.31%	22,754 $3.37 Million
Q2 2020 Jul 06, 2020	BUY	$136.42 - $164.18 $2.08 Million - $2.5 Million	15,252 Added 240.04%	21,606 $3.55 Million
Q1 2020 Apr 03, 2020	BUY	$119.05 - $147.35 $153,693 - $190,228	1,291 Added 25.5%	6,354 $882,000
Q4 2019 Jan 24, 2020	BUY	$106.92 - $132.43 $34,642 - $42,907	324 Added 6.84%	5,063 $665,000
Q3 2019 Oct 03, 2019	SELL	$106.79 - $116.16 $28,192 - $30,666	-264 Reduced 5.28%	4,739 $530,000
Q1 2019 Apr 03, 2019	BUY	$111.31 - $131.02 $51,870 - $61,055	466 Added 10.27%	5,003 $649,000
Q4 2018 Jan 03, 2019	SELL	$105.9 - $118.64 $5,295 - $5,932	-50 Reduced 1.09%	4,537 $525,000
Q3 2018 Oct 03, 2018	SELL	$85.86 - $107.31 $12,277 - $15,345	-143 Reduced 3.02%	4,587 $492,000
Q4 2017 Jan 04, 2018	SELL	$81.94 - $87.89 $24,663 - $26,454	-301 Reduced 5.98%	4,730 $400,000
Q3 2017 Oct 04, 2017	BUY	$77.07 - $85.54 $387,739 - $430,351	5,031	5,031 $431,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.

Account